Search research articles
Contact Us
Filters
Showing results (171-180 of 222) with videos related to
Page
of 23
Sort By:
Journal of Psychiatric Research
|
November 14, 2012
Cannabis withdrawal in chronic cannabis users with schizophrenia
Douglas L Boggs, Deanna L Kelly, Fang Liu, et al.
Pharmacology, Biochemistry, and Behavior
|
April 1, 1996
Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909
G I Elmer, A Brockington, D A Gorelick, et al.
Clinical Chemistry
|
August 31, 2011
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration
Garry Milman, David M Schwope, Eugene W Schwilke, et al.
Life Sciences
|
January 1, 1996
Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys
G N Carmona, I Baum, C W Schindler, et al.
Schizophrenia Bulletin
|
November 5, 2014
Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia
Robert W Buchanan, Elaine Weiner, Deanna L Kelly, et al.
Schizophrenia Research
|
December 4, 2014
Risk-taking in schizophrenia and controls with and without cannabis dependence
Bernard A Fischer, Robert P McMahon, Deanna L Kelly, et al.
Analytical and Bioanalytical Chemistry
|
June 4, 2011
Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration
Garry Milman, Allan J Barnes, David M Schwope, et al.
Heliyon
|
January 3, 2024
A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals
Derek A Abbott, Maureen G Mancini, Michael J Bolt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 19, 2000
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans
G N Carmona, R A Jufer, S R Goldberg, et al.
The American Journal on Addictions
|
July 27, 2006
Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use
Marc L Copersino, Susan J Boyd, Donald P Tashkin, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 222) with videos related to
Sort By:
Page
of 23
Journal of Psychiatric Research
|
November 14, 2012
Cannabis withdrawal in chronic cannabis users with schizophrenia
Douglas L Boggs, Deanna L Kelly, Fang Liu, et al.
Pharmacology, Biochemistry, and Behavior
|
April 1, 1996
Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909
G I Elmer, A Brockington, D A Gorelick, et al.
Clinical Chemistry
|
August 31, 2011
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration
Garry Milman, David M Schwope, Eugene W Schwilke, et al.
Life Sciences
|
January 1, 1996
Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys
G N Carmona, I Baum, C W Schindler, et al.
Schizophrenia Bulletin
|
November 5, 2014
Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia
Robert W Buchanan, Elaine Weiner, Deanna L Kelly, et al.
Schizophrenia Research
|
December 4, 2014
Risk-taking in schizophrenia and controls with and without cannabis dependence
Bernard A Fischer, Robert P McMahon, Deanna L Kelly, et al.
Analytical and Bioanalytical Chemistry
|
June 4, 2011
Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration
Garry Milman, Allan J Barnes, David M Schwope, et al.
Heliyon
|
January 3, 2024
A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals
Derek A Abbott, Maureen G Mancini, Michael J Bolt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 19, 2000
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans
G N Carmona, R A Jufer, S R Goldberg, et al.
The American Journal on Addictions
|
July 27, 2006
Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use
Marc L Copersino, Susan J Boyd, Donald P Tashkin, et al.
Page
of 23